Increased levels of cysteinyl-leukotrienes in saliva, induced sputum, urine and blood from patients with aspirin-intolerant asthma

Thorax

Volumn 63, Issue 12, 2008, Pages 1076-1082

  Gaber, F ^a   Daham, K ^a,b   Higashi, A ^a   Higashi, N ^a   Gulich A ^a,b   Delin, I ^a   James, A ^a,b   Skedinger, M ^a,b   Gyllfors, P ^a,b   Nord, M ^a,b   Dahlen S E ^a,b   Kumlin, M ^a,c   Dahlen B ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c SOPHIAHEMMET UNIVERSITY COLLEGE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

11 EPIPROSTAGLANDIN F2 ALPHA; ACETYLSALICYLIC ACID; ALLERGEN; BIOLOGICAL MARKER; LEUKOTRIENE B4; LYSINE ACETYLSALICYLATE; NITRIC OXIDE; PEPTIDOLEUKOTRIENE;

ADULT; ARTICLE; ASTHMA; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; EX VIVO STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROVOCATION TEST; SALIVA LEVEL; SPUTUM LEVEL; URINE LEVEL;

EID: 57149099835     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2008.101196     Document Type: Article

References (32)

1. Dahlen B. Treatment of aspirin-intolerant asthma with antileukotrienes. Am J Respir Crit Care Med 2000;161:S137-41.
2. Stevenson DD, Szczeklik A. Clinical and pathologic perspectives on aspirin sensitivity and asthma. J Allergy Clin Immunol 2006;118:773-8.
3. Szczeklik A, Nizankowska E. Clinical features and diagnosis of aspirin induced asthma. Thorax 2000;55(Suppl 2):S42-4.
4. Szczeklik A, Gryglewski RJ, Czerniawska-Mysik G. Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. BMJ 1975;1:67-9.
5. Gyllfors P, Bochenek G, Overholt J, et al. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. J Allergy Clin Immunol 2003;111:1116-21.
6. O'Sullivan S, Dahlen B, Dahlen SE, et al. Increased urinary excretion of the prostaglandin D2 metabolite 9 alpha, 11 beta-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol 1996;98:421-32.
7. Dahlen B, Kumlin M, Margolskee DJ, et al. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur Respir J 1993;6:1018-26.
8. Chanez P, Wenzel SE, Anderson GP, et al. Severe asthma in adults: what are the important questions? J Allergy Clin Immunol 2007;119:1337-48.
9. Kumlin M. Measurement of leukotrienes in humans. Am J Respir Crit Care Med 2000;161:8102-6.
10. Higashi N, Taniguchi M, Mita H, et al. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol 2004;113:277-83.
11. Obase Y, Shimoda T, Tomari SY, et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients. Chest 2002;121:143-50.
12. Sanak M, Levy BD, Clish CB, et al. Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Hespir J 2000;16:44-9.
13. Sanz ML, Gamboa P, de Weck AL A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs. Int Arch Allergy Immunol 2005;136:58-72.
14. Gaber F, James A, Delin I, et al. Assessment of in vivo 5-lipoxygenase activity by analysis of leukotriene B4 in saliva: effects of treatment with zileuton. J Allergy Clin Immunol 2007;119:1267-8.
15. Lawrence HP. Salivary markers of systemic disease: noninvasive diagnosis of disease and monitoring of general health. J Can Dent Assoc 2002;68:170-4.
16. Broeckaert F, Clippe A, Knoops B, et al. Clara cell secretory protein (CC16): features as a peripheral lung biomarker. Ann NY Acad Sci 2000;923:68-77.
17. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, et al. EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy 2007;62:1111-8.
18. ATS/ERS. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005;171:912- 30.
19. Gyllfors P, Kumlin M, Dahlen SE, et al. Relation between bronchial responsiveness to inhaled leukotriene D4 and markers of leukotriene biosynthesis. Thorax 2005;60:902-8.
20. Brannan JD, Gulliksson M, Anderson SD, et al. Inhibition of mast cell PGD2 release protects against mannitol-induced airway narrowing. Eur Respir J 2006;27:944-50.
21. Bland JM, Altman DG. Measurement error and correlation coefficients. BMJ 1996;313:41-2.
22. Nasser SM, Patel M, Bell GS, et al. The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma. Am J Respir Crit Care Med 1995;151:1326-30.
23. Cowburn AS, Sladek K, Soja J, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998;101:834-46.
24. Martinez Molina D, Wetterholm A, Kohl A, et al. Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase. Nature 2007;448:613-6.
25. Mattes J, Storm van's Gravesande K. Reining U. et al. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma. Eur Respir J 1999;13:1391-5.
26. Bisgaard H, Loland L, Oj JA. NO in exhaled air of asthmatic children is reduced by the teukotriene receptor antagonist montelukast. Am J Respir Crit Care Med 1999;160:1227-31.
27. Rolla G, Di Emanuele A, Dutto L. et al. Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma. Allergy 2004;59:827-32.
28. Gaber F, Acevedo F. Delin I. et al. Saliva is one likely source of leukotriene B4 in exhaled breath condensate. Eur Respir J 2006;28:1229-35.
29. Maclouf J, Antoine C. De Caterina R, et al. Entry rate and metabolism of leukotriene C4 into vascular compartment in healthy subjects. Am J Physiol 1992;263:H244-9
30. Green FA. Claesson HE, Hamberg M. Lipoxygenase products from polymorphonuclear leukocytes and epithelial cells of human saliva. Arch Biochem Biophys 1987;257:321-7.
31. Wallaert B, Janin A. Lassalle P, et al. Airway-like inflammation of minor salivary gland in bronchial asthma. Am J Respir Crit Care Med 1994;150:802-9.
32. Patan-Golden M. Henderson WR Jr. Leukotrienes. N Engl J Med 2007;357: 1841-54.